Xbrane Biopharma AB (publ) (”Xbrane” eller ”Company”) (Nasdaq Stockholm: XBRANE), a leading Biosimilar Developer invites to a webcast related to the announcement of the commercialization and license agreement for Xcimzane™

Webcast

Xbrane will host a webcast for investors, analysts, and media, where CEO Martin Åmark will present and reason around the entered commercialization and license agreement for Xcimzane. The presentation will be held in English.

The webcast is held tomorrow Tuesday February 8th, 10:00-10:45. Please register using the following link:

Weblink

https://tv.streamfabriken.com/xbrane-biopharma-press-conference-2022

Participant dial in number

SE: +46 8 505 583 56
UK: +44 3 333 009 032
US: +1 631 913 14 22 PIN US: 419 68 092#

© Modular Finance, source Nordic Press Releases